Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.
|Title of host publication||Handbook of Polymers for Pharmaceutical Technologies|
|Subtitle of host publication||Biodegradable Polymers|
|Number of pages||43|
|Publication status||Published - 19 Sep 2015|